NOLIAC
Financials
Estimates*
EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|---|
EBITDA | (<1m) | <1m | <1m | 1.8m | 1.8m | 1.8m | 1.2m |
Profit | <1m | <1m | (<1m) | <1m | 1.2m | (1.1m) | 7.3m |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
€260k | Grant | ||
€1.1m | Grant | ||
N/A | Acquisition | ||
Total Funding | €1.4m |
Related Content
Recent News about NOLIAC
EditNoliac, a part of CTS Corporation, specializes in the design, development, and manufacturing of high-quality piezoelectric components and systems. Operating primarily in the healthcare sector, Noliac provides custom-designed ultrasonic transducers and piezo components for a variety of medical applications, including ultrasonic surgery devices. The company serves a broad range of industries, including industrial equipment, automotive, aerospace, and optical communications, leveraging its expertise in piezoelectric technology to deliver tailored solutions. Noliac's business model revolves around creating value through innovation and customization, offering products that range from raw piezoelectric materials to fully integrated plug-and-play systems. Revenue is generated through the sale of these specialized components and systems, catering to clients who require precise and reliable piezoelectric solutions. The company benefits from being part of CTS Corporation, which enhances its capabilities and market reach.
Keywords: piezoelectric, ultrasonic transducers, healthcare, custom solutions, industrial equipment, automotive, aerospace, optical communications, innovation, CTS Corporation.